药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Flurandrenolide
Flumequine
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Flumequine.
Flurandrenolide
Chlorcyclizine
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Chlorcyclizine.
Flurandrenolide
Eribulin
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Eribulin.
Flurandrenolide
Rilpivirine
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Rilpivirine.
Flurandrenolide
Bupranolol
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Bupranolol.
Flurandrenolide
Geranylgeranyl diphosphate
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Geranylgeranyl diphosphate.
Flurandrenolide
Farnesyl diphosphate
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Farnesyl diphosphate.
Flurandrenolide
Triptorelin
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Triptorelin.
Flurandrenolide
Histrelin
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Histrelin.
Flurandrenolide
Buserelin
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Buserelin.
Flurandrenolide
Degarelix
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Degarelix.
Flurandrenolide
Pasireotide
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Pasireotide.
Flurandrenolide
Cariporide
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Cariporide.
Flurandrenolide
Vernakalant
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Vernakalant.
Flurandrenolide
Tandutinib
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Tandutinib.
Flurandrenolide
Farnesyl thiopyrophosphate
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Farnesyl thiopyrophosphate.
Flurandrenolide
Fleroxacin
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Fleroxacin.
Flurandrenolide
Vorinostat
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Vorinostat.
Flurandrenolide
Pheniramine
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Pheniramine.
Flurandrenolide
Hydroxychloroquine
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Hydroxychloroquine.